Source-identifying biomarker ions between environmental and clinical Burkholderia pseudomallei using whole-cell Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS)

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Niyompanich, Suthamat ^a   Jaresitthikunchai, Janthima ^b   Srisanga, Kitima ^a   Roytrakul, Sittiruk ^b   Tungpradabkul, Sumalee ^a  

^a Mahidol University   (Thailand)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ION;

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BURKHOLDERIA PSEUDOMALLEI; CLINICAL LABORATORY; COMPARATIVE STUDY; CONTROLLED STUDY; ENVIRONMENT; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; WHOLE CELL; CLUSTER ANALYSIS; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; MICROBIOLOGY; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES;

BIOLOGICAL MARKERS; BURKHOLDERIA PSEUDOMALLEI; CLUSTER ANALYSIS; ENVIRONMENTAL MICROBIOLOGY; IONS; PRINCIPAL COMPONENT ANALYSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84902590136     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099160     Document Type: Article

References (53)

1. Cheng AC, Currie BJ (2005) Melioidosis: epidemiology, pathophysiology, and management. Clinical microbiology reviews 18: 383-416. (Pubitemid 40548298)
2. Wiersinga WJ, Currie BJ, Peacock SJ (2012) Melioidosis. The New England journal of medicine 367: 1035-1044.
3. Galyov EE, Brett PJ, DeShazer D (2010) Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annual review of microbiology 64: 495-517.
4. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ (2006) Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nature reviews Microbiology 4: 272-282.
5. Jenney AW, Lum G, Fisher DA, Currie BJ (2001) Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. International journal of antimicrobial agents 17: 109-113. (Pubitemid 32101565)
6. Vuddhakul V, Tharavichitkul P, Na-Ngam N, Jitsurong S, Kunthawa B, et al. (1999) Epidemiology of Burkholderia pseudomallei in Thailand. The American journal of tropical medicine and hygiene 60: 458-461. (Pubitemid 29162131)
7. Trakulsomboon S, Vuddhakul V, Tharavichitkul P, Na-Gnam N, Suputtamongkol Y, et al. (1999) Epidemiology of arabinose assimilation in Burkholderia pseudomallei isolated from patients and soil in Thailand. The Southeast Asian journal of tropical medicine and public health 30: 756-759.
8. Rattanavong S, Wuthiekanun V, Langla S, Amornchai P, Sirisouk J, et al. (2011) Randomized soil survey of the distribution of Burkholderia pseudomallei in rice fields in Laos. Applied and environmental microbiology 77: 532-536.
9. Chen Y-S, Lin H-H, Mu J-J, Chiang C-S, Chen C-H, et al. (2010) Distribution of melioidosis cases and viable Burkholderia pseudomallei in soil: evidence for emerging melioidosis in Taiwan. Journal of clinical microbiology 48: 1432-1434.
10. Ulett GC, Currie BJ, Clair TW, Mayo M, Ketheesan N, et al. (2001) Burkholderia pseudomallei virulence: definition, stability and association with clonality. Microbes and infection/Institut Pasteur 3: 621-631.
11. Haase A, Smith-Vaughan H, Melder A, Wood Y, Janmaat A, et al. (1995) Subdivision of Burkholderia pseudomallei ribotypes into multiple types by random amplified polymorphic DNA analysis provides new insights into epidemiology. Journal of clinical microbiology 33: 1687-1690.
12. Haase A, Janzen J, Barrett S, Currie B (1997) Toxin production by Burkholderia pseudomallei strains and correlation with severity of melioidosis. Journal of Medical Microbiology 46: 557-563. (Pubitemid 27298765)
13. Liew SM, Tay ST, Wongratanacheewin S, Puthucheary SD (2012) Enzymatic profiling of clinical and environmental isolates of Burkholderia pseudomallei. Tropical biomedicine 29: 160-168.
14. Sermswan RW, Wongratanacheewin S, Trakulsomboon S, Thamlikitkul V (2001) Ribotyping of Burkholderia pseudomallei from clinical and soil isolates in Thailand. Acta Tropica 80: 237-244. (Pubitemid 33043969)
15. Inglis TJ, Garrow SC, Henderson M, Clair A, Sampson J, et al. (2000) Burkholderia pseudomallei traced to water treatment plant in Australia. Emerging infectious diseases 6: 56-59. (Pubitemid 30126454)
16. Winstanley C, Hales BA, Corkill JE, Gallagher MJ, Hart CA (1998) Flagellin gene variation between clinical and environmental isolates of Burkholderia pseudomallei contrasts with the invariance among clinical isolates. Journal of medical microbiology 47: 689-694. (Pubitemid 28342816)
17. Leelayuwat C, Romphruk A, Lulitanond A, Trakulsomboon S, Thamlikitkul V (2000) Genotype analysis of Burkholderia pseudomallei using randomly amplified polymorphic DNA (RAPD): indicative of genetic differences amongst environmental and clinical isolates. Acta tropica 77: 229-237.
18. Norton R, Roberts B, Freeman M, Wilson M, Ashhurst-Smith C, et al. (1998) Characterisation and molecular typing of Burkholderia pseudomallei: are disease presentations of melioidosis clonally related? FEMS immunology and medical microbiology 20: 37-44. (Pubitemid 28075418)
19. Cheng AC, Godoy D, Mayo M, Gal D, Spratt BG, et al. (2004) Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation. Journal of clinical microbiology 42: 5477-5483. (Pubitemid 39664324)
20. Vesaratchavest M, Tumapa S, Day NPJ, Wuthiekanun V, Chierakul W, et al. (2006) Nonrandom distribution of Burkholderia pseudomallei clones in relation to geographical location and virulence. Journal of clinical microbiology 44: 2553-2557. (Pubitemid 44092426)
21. Bartpho T, Wongsurawat T, Wongratanacheewin S, Talaat AM, Karoonuthaisiri N, et al. (2012) Genomic islands as a marker to differentiate between clinical and environmental Burkholderia pseudomallei. PLoS ONE 7: e0037762.
22. Sauer S, Kliem M (2010) Mass spectrometry tools for the classification and identification of bacteria. Nature reviews Microbiology 8: 74-82.
23. Welker M, Moore ERB (2011) Applications of whole-cell matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry in systematic microbiology. Systematic and applied microbiology 34: 2-11.
24. Murray PR (2010) Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: usefulness for taxonomy and epidemiology. Clinical Microbiology and Infection 16: 1626-1630.
25. Krásný L, Hynek R, Hochel I (2013) Identification of bacteria using mass spectrometry techniques. International Journal of Mass Spectrometry 353: 67-79.
26. Carbonnelle E, Mesquita C, Bille E, Day N, Dauphin B, et al. (2011) MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory. Clinical Biochemistry 44: 104-109.
27. Intelicato-Young J, Fox A (2013) Mass spectrometry and tandem mass spectrometry characterization of protein patterns, protein markers and whole proteomes for pathogenic bacteria. Journal of microbiological methods 92: 381-386.
28. Sandrin TR, Goldstein JE, Schumaker S (2013) MALDI TOF MS profiling of bacteria at the strain level: a review. Mass spectrometry reviews 32: 188-217.
29. Wolters M, Rohde H, Maier T, Belmar-Campos C, Franke G, et al. (2011) MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages. International journal of medical microbiology: IJMM 301: 64-68.
30. Siegrist TJ, Anderson PD, Huen WH, Kleinheinz GT, McDermott CM, et al. (2007) Discrimination and characterization of environmental strains of Escherichia coli by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Journal of microbiological methods 68: 554-562. (Pubitemid 46343569)
31. Rajakaruna L, Hallas G, Molenaar L, Dare D, Sutton H, et al. (2009) High throughput identification of clinical isolates of Staphylococcus aureus using MALDI-TOF-MS of intact cells. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 9: 507-513.
32. Dieckmann R, Helmuth R, Erhard M, Malorny B (2008) Rapid classification and identification of Salmonellae at the species and subspecies levels by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry. Applied and environmental microbiology 74: 7767-7778.
33. Giebel RA, Fredenberg W, Sandrin TR (2008) Characterization of environmental isolates of Enterococcus spp. by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Water research 42: 931-940. (Pubitemid 351231959)
34. Marklein G, Josten M, Klanke U, Müller E, Horré R, et al. (2009) Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. Journal of Clinical Microbiology 47: 2912-2917.
35. Tanigawa K, Kawabata H, Watanabe K (2010) Identification and typing of Lactococcus lactis by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Applied and environmental microbiology 76: 4055-4062.
36. Donohue MJ, Smallwood AW, Pfaller S, Rodgers M, Shoemaker JA (2006) The development of a matrix-assisted laser desorption/ionization mass spectrometry-based method for the protein fingerprinting and identification of Aeromonas species using whole cells. Journal of microbiological methods 65: 380-389. (Pubitemid 44275211)
37. Eddabra R, Prévost G, Scheftel J-M (2012) Rapid discrimination of environmental Vibrio by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Microbiological research 167: 226-230.
38. Sauer S, Freiwald A, Maier T, Kube M, Reinhardt R, et al. (2008) Classification and identification of bacteria by mass spectrometry and computational analysis. PloS one 3: e0002843.
39. Demirev PA, Fenselau C (2008) Mass spectrometry in biodefense. Journal of mass spectrometry: JMS 43: 1441-1457.
40. Rotz LD (2002) Public health assessment of potential biological terrorism agents. Emerging Infectious Diseases 8: 225-230.
41. Karger A, Stock R, Ziller M, Elschner MC, Bettin B, et al. (2012) Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell Matrix-assisted Laser Desorption/Ionisation mass spectrometric typing. BMC Microbiology 12.
42. Seng P, Drancourt M, Gouriet F, La Scola B, Fournier P-E, et al. (2009) Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 49: 543-551.
43. Chantratita N, Wuthiekanun V, Boonbumrung K, Tiyawisutsri R, Vesaratchavest M, et al. (2007) Biological relevance of colony morphology and phenotypic switching by Burkholderia pseudomallei. Journal of bacteriology 189: 807-817. (Pubitemid 46183855)
44. Lau SKP, Tang BSF, Curreem SOT, Chan T-M, Martelli P, et al. (2012) Matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid identification of Burkholderia pseudomallei: importance of expanding databases with pathogens endemic to different localities. Journal of Clinical Microbiology 50: 3142-3143.
45. Valentine N, Wunschel S, Wunschel D, Petersen C, Wahl K (2005) Effect of culture conditions on microorganism identification by matrix-assisted laser desorption ionization mass spectrometry. Applied and Environmental Microbiology 71: 58-64. (Pubitemid 40116250)
46. Currie B, Smith-Vaughan H, Golledge C, Buller N, Sriprakash KS, et al. (1994) Pseudomonas pseudomallei isolates collected over 25 years from a non-tropical endemic focus show clonality on the basis of ribotyping. Epidemiology and infection 113: 307-312. (Pubitemid 24310319)
47. Dance DA (2000) Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta tropica 74: 159-168.
48. Baker A, Mayo M, Owens L, Burgess G, Norton R, et al. (2013) Biogeography of Burkholderia pseudomallei in the Torres Strait Islands of Northern Australia. Journal of Clinical Microbiology.
49. Holden MTG, Titball RW, Peacock SJ, Cerden̈o-Tárraga AM, Atkins T, et al. (2004) Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proceedings of the National Academy of Sciences of the United States of America 101: 14240-14245.
50. Ketterlinus R, Hsieh S-Y, Teng S-H, Lee H, Pusch W (2005) Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software. BioTechniques Suppl: 37-40.
51. Niumsup P, Wuthiekanun V (2002) Cloning of the class D beta-lactamase gene from Burkholderia pseudomallei and studies on its expression in ceftazidime-susceptible and -resistant strains. The Journal of antimicrobial chemotherapy 50: 445-455. (Pubitemid 35214782)
52. Tungpradabkul S, Wajanarogana S, Tunpiboonsak S, Panyim S (1999) PCR-RFLP analysis of the flagellin sequences for identification of Burkholderia pseudomallei and Burkholderia cepacia from clinical isolates. Molecular and cellular probes 13: 99-105. (Pubitemid 29206408)
53. Subsin B, Thomas MS, Katzenmeier G, Shaw JG, Tungpradabkul S, et al. (2003) Role of the stationary growth phase sigma factor RpoS of Burkholderia pseudomallei in response to physiological stress conditions. J Bacteriol 185: 7008-7014. (Pubitemid 37444504)